Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Achieving Personalized Medicine With Proteomics – Translating Proteomics Episode 8

Key Takeaway: The latest episode of 'Translating Proteomics' discusses the role of proteomics in drug development and personalized medicine. Hosts Dr. Parag Mallick and Dr. Andreas Huhmer explore how proteomics can identify effective drug targets and improve the precision of drug development. They highlight the advancements in proteomics technologies that are reshaping the landscape of drug discovery.
Price reaction · baseline $2.22 (2024-06-26 close) · hit after-hours · clean, no other NAUT news in the window
day 0 close
+2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Proteomics offers high-resolution insights into biological functions.
  • The podcast aims to enhance understanding of drug development.
  • Personalized medicine approaches are being advanced through proteomics.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Proteomics
Nautilus Biotechnology
June 26, 2024
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery , drug development , food and energy security, and a range of other timely topics. The goal of these conversations is to expose you to important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
Your hosts are Drs. Parag Mallick and Andreas Huhmer of Nautilus Biotechnology. Parag is an Associate Professor at Stanford University whose lab performs systems biology studies that drive precision medicine approaches for cancer diagnosis and treatment. Andreas is a veteran scientist whose industry work has supported thousands of proteomics researchers by helping to bring the latest mass spec technologies into their labs.

Episode 8 – Expanding the Druggable Universe with Proteomics

Despite incredible leaps in our understanding of molecular biology, the majority of drug development efforts still fail, and those that succeed often fail to return investment dollars. Proteomics has the potential to change that by providing high-resolution views of the biochemical drivers of biological function – proteins. In this episode of Translating Proteomics, Parag and Andreas discuss how proteomics can help researchers identify good drug targets, personalize drug development, and advance precision medicine.
Chapters:
00:00 – How do we define good drug targets and “druggable” in the age of proteomics 08:16 – Advancing personalized medicine through proteomics 10:58 – How proteomics technologies have changed drug development 15:13 – New abilities next-generation proteomics technologies give us in drug development
Some key points of discussion:
• What makes a good drug target
• How we can better personalize drug development
• How proteomics has and will change drug development
Listen to Translating Proteomics Episode 14: Expanding the Drug Development Toolkit with Proteomics as a great follow-up to this episode!
Subscribe to the Translating Proteomics podcast on YouTube , Apple Podcasts , Spotify , or your favorite podcast outlet
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
Proteomics and popular culture
We're giving the proteome a PR boost by highlighting ways proteomics can interact with your life in both healthcare and popular culture.
Read more
Traditional protein analysis methods – Western blotting, flow cytometry, and other methods using affinity reagents
There are many existing protein analysis methods using affinity reagents, and all come with advantages and disadvantages.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is the focus of Translating Proteomics Episode 8?

Episode 8 focuses on how proteomics can improve drug development and personalize medicine.

Who are the hosts of the Translating Proteomics podcast?

The hosts are Dr. Parag Mallick and Dr. Andreas Huhmer from Nautilus Biotechnology.

How does proteomics impact drug development?

Proteomics provides insights into biochemical drivers, helping identify effective drug targets.

What advancements are discussed in this episode?

The episode discusses advancements in proteomics technologies that enhance drug discovery.

Last updated: Jun 26, 2024